Combining VEGF receptor inhibitors and angiotensin-(1-7) to target renal cell carcinoma.

Walther, Thomas; Khanna, Prateek; Bhatt, Rupal S

Walther, Thomas; Khanna, Prateek; Bhatt, Rupal S.

Afiliação

Walther T; Department of Pharmacology and Therapeutics, School of Medicine and School of Pharmacy, University College Cork, Cork, Ireland.
Khanna P; Institute of Medical Biochemistry and Molecular Biology, University Medicine Greifswald, Greifswald, Germany.
Bhatt RS; Division of Hematology-Oncology and Cancer Biology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

Mol Cell Oncol ; 8(4): 1918529, 2021.

Article em En | MEDLINE | ID: mdl-34616864

Palavras-chave

ACE2; Ang-(17); RCC; VEGFR-TKI; resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Mol Cell Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google